Truvada Settlement
Truvada Settlement
Available 24/7
Get Help

Free Consultation

File Your Claim Request Today


Contact Preference

You May Be Entitled to Significant Compensation

TDF drugs are used in conjunction with other HIV medications to help control HIV infections. The medications are also used for individuals who have a high risk of developing HIV. Gilead Sciences manufactures five TDF drugs: Truvada, Viread, Atripla, Complera, and Stribild.

All five drugs have been linked to adverse effects, including kidney failure, bone fractures, or death, according to to the U.S. Food and Drug Administration.

Truvada is one of the most common preventative medicines against HIV. For nearly 15 years, its manufacturer, Gilead Sciences, Inc., withheld Truvada’s fatal side effects of kidney and bone damage from patients and doctors. Individuals filed cases asserting Gilead dismissed this information in order to keep its patent on Truvada and maximize profits. You may be entitled to a substantial settlement if you took any of Gilead’s TDF drugs and were diagnosed with any of the following:

  • Acute kidney injuries
  • Chronic kidney disease
  • Kidney failure
  • Bone fractures
  • Osteoporosis
  • Osteopenia
  • Other kidney and bone-related issues

Hold Gilead Responsible

Make sure companies like Gilead provide warning of potentially fatal side effects.

Evidence shows that Gilead knew about the toxicity of its drug when taken in large doses but failed to warn users and purposely postponed releasing a safer alternative. Profiting off patients’ health is inexcusable. File your claim today to hold Gilead responsible for putting consumers at risk during HIV-prevention.

Gilead’s Deceptive Conduct

The active ingredient in Truvada, Viread, Atripla, Complera, and Stribild is tenofovir disoproxil fumarate (TDF), which has been proven to diminish bone density by 2-6% and weaken kidney function. In the past few years, Truvada users brought their health cases to the public to confirm Gilead manipulated patients’ health for profits.

The FDA warned Gilead several times about its misleading marketing that downplayed the health risks of its 5 TDF drugs. With more than 80% of patients taking one of Gilead’s products daily, the company has maintained total control of the HIV treatment market. Its monopoly and $80 billion in sales could explain Gilead’s deception with its products’ adverse side effects.

People have suffered because of Gilead’s negligence. If you or a loved one have taken Truvada or any of the other TDF drugs and were diagnosed with kidney or bone problems, the time to file a claim is now. Join the thousands of individuals holding Gilead responsible to keep future users safe.